Bengaluru-based startup Biopeak, India’s first full-stack precision health platform, has launched the country’s first longevity clinic with a mission to transform the way healthcare is experienced; shifting the focus from treating illness to optimising everyday health and performance.
At Biopeak, longevity is defined not by the number of years lived, but by the quality of those years. The clinic is built on the principle of ‘Unlock Limitless Living’, removing barriers that prevent individuals from performing, thriving, and enjoying life to the fullest.
Unlike a conventional doctor’s appointment, Biopeak’s longevity clinic offers an in-depth, hours-long evaluation of an individual’s health. Programs begin with advanced assessments, including 130+ biomarker blood panels, DEXA scans, VO₂ max testing, genetic and epigenetic profiling, gut and oral microbiome mapping, and hormonal analysis.
Founded by Rishi Pardal and Shiva Subramanian, Biopeak is backed by marquee investors including Nikhil Kamath (NKSquared, Zerodha), Dr Ranjan Pai (Claypond Capital), and Prashanth Prakash (Accel). Its programmes are shaped by a multidisciplinary advisory board of Indian and global experts, including Dr Satchidananda Panda (circadian biology, Salk Institute), Dr Harald Stossier (Modern Mayr Medicine pioneer), and Irina Sharma (LiveWell).
What sets Biopeak apart is its end-to-end model: diagnostics, insight generation, and continuous expert support are all integrated into one system. Unlike providers that stop at testing, Biopeak translates data into actionable strategies and partners with clients until measurable outcomes are achieved. By combining global science with Indian biology, Biopeak ensures its health programmes are deeply relevant for Indian bodies and lifestyles.
